Firms

Founded

—

Type

Venture capital

Team

No team members on record yet.

Co-investing

3E Bioventures Capital

• DewPoint Therapeutics, Inc.$150M · 2022-02-03
• Dewpoint$150M · 2022
• DewPoint Therapeutics, Inc.$150M · Unknown date

ARCH Venture Partners

• DewPoint Therapeutics, Inc.$150M · 2022-02-03
• Dewpoint$150M · 2022
• DewPoint Therapeutics, Inc.$150M · Unknown date

General Catalyst

• DewPoint Therapeutics, Inc.$150M · 2022-02-03
• Dewpoint$150M · 2022
• DewPoint Therapeutics, Inc.$150M · Unknown date

Leaps by Bayer

• DewPoint Therapeutics, Inc.$150M · 2022-02-03
• Dewpoint$150M · 2022
• DewPoint Therapeutics, Inc.$150M · Unknown date

Maverick Ventures

• DewPoint Therapeutics, Inc.$150M · 2022-02-03
• Dewpoint$150M · 2022
• DewPoint Therapeutics, Inc.$150M · Unknown date

SHOW MORE

Investments

$150M2022-02-03	DewPoint Therapeutics, Inc.	General Catalyst, 3E Bioventures Capital, NS Investment, Leaps by Bayer, Polaris Partners, Samsara BioCapital, ARCH Venture Partners, Mirae Asset Capital, Maverick Ventures, Mubadala Capital
$150M2022	Dewpoint	ARCH Venture Partners, Leaps by Bayer, Maverick Ventures, Mirae Asset, General Catalyst, 3E Bioventures Capital, NS Investment
$150MUnknown date	DewPoint Therapeutics, Inc.	ARCH Venture Partners, Leaps by Bayer, Maverick Ventures, Mirae Asset, General Catalyst, 3E Bioventures Capital, NS Investment

SHOW MORE